May
23, 2012 06:30 AM Eastern Daylight Time Partnership Expands Access to
Large-Scale Whole Genome SequencingSAN DIEGO--(BUSINESS WIRE)--Illumina, Inc.
(NASDAQ:ILMN) today announced that the Cold Spring Harbor Laboratory (CSHL) has
joined the Illumina Genome Network (IGN) to provide researchers with broader
access to whole genome sequencing (WGS) services. IGN and CSHL will work in
collaboration to bring together CSHL’s expertise in molecular biology and
cancer genomics with Illumina’s industry-leading sequencing technology. “The goal of our work at
the Cold Spring Harbor Laboratory is to apply our research on basic biological
mechanisms to improve the diagnosis and treatment of cancer, as well as
neurological disorders and other diseases” . “We welcome the distinguished Cold Spring
Harbor Laboratory to our prestigious group of IGN partners, and are excited to
expand opportunities for deep scientific collaboration,” said Christian Henry,
Senior Vice President and General Manager of Illumina’s Genomic Solutions
Business. “Through the Illumina Genome Network, we believe we can speed
discovery in areas where CSHL excels, including approaches to understanding
tumor development, progression and therapeutic response.”“The goal of our work at
the Cold Spring Harbor Laboratory is to apply our research on basic biological
mechanisms to improve the diagnosis and treatment of cancer, as well as
neurological disorders and other diseases,” said Richard McCombie, Professor,
Cold Spring Harbor Laboratory. “By participating in IGN, we are enriching the
capabilities of researchers as they strive to solve biology’s most challenging
problems.”IGN links researchers needing large-scale, whole human genome
sequencing with world class institutions that provide this service, and
delivers unmatched access to the highest quality of whole genome sequencing
data. All IGN partners are experienced and well-published using Illumina
TruSeq™ technology, and have completed Illumina’s Certified Service Provider
(CSPro) certification. Each possesses ten or more Illumina sequencing systems
(HiSeq 2000 systems and/or Genome Analyzers), providing the scalability to
handle large sequencing projects with rapid completion times.
No comments:
Post a Comment